Literature DB >> 8936895

Additive benefits of laxative, toilet training, and biofeedback therapies in the treatment of pediatric encopresis.

D J Cox1, J Sutphen, W Ling, W Quillian, S Borowitz.   

Abstract

Compared the additive benefits of laxative, behavior, and biofeedback treatments for encopresis, while attempting to identify treatment mechanisms and predictors of treatment outcome. 44 encopretic children, ages 6-15 years, were randomly assigned to either laxative therapy (LAX), LAX plus enhanced toilet training (ETT), or LAX + ETT + anal sphincter biofeedback (BF). Daily symptom diaries were completed 14 days before, upon initiation of and 3 months following treatment initiation. ETT and BF were superior to LAX in reducing encopresis. Outcome was significantly predicted by improvement during the initial 14 days of treatment. Reduction of soiling was associated with an increase in bowel movement frequency, and reductions in defecation pain and parental prompting to use the toilet. Because of its efficacy and minimal reliance on technology, ETT should be the initial treatment of choice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8936895     DOI: 10.1093/jpepsy/21.5.659

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  4 in total

Review 1.  Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children.

Authors:  Miriam Brazzelli; Peter V Griffiths; June D Cody; David Tappin
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Encopresis.

Authors:  D R Patel; H D Pratt
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

3.  Psychosocial co-morbidity affects treatment outcome in children with fecal incontinence.

Authors:  Els Q van Everdingen-Faasen; Bert J Gerritsen; Paul G H Mulder; Ellen A Fliers; Michael Groeneweg
Journal:  Eur J Pediatr       Date:  2007-10-19       Impact factor: 3.183

Review 4.  Measuring the symptoms of pediatric constipation and irritable bowel syndrome with constipation: expert commentary and literature review.

Authors:  Robert A Arbuckle; Robyn T Carson; Linda Abetz-Webb; Jeffrey Hyams; Carlo Di Lorenzo; Barbara E Lewis; Elizabeth Gargon; Caroline Kurtz; Steven J Shiff; Jeffrey M Johnston
Journal:  Patient       Date:  2014       Impact factor: 3.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.